Polypeptide films and methods
Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.
1. A multilayer film, the film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes,
wherein a first layer polyelectrolyte comprises a first layer polypeptide comprising one or more first amino acid sequence motifs,
wherein the one or more first amino acid sequence motifs consists of 5 to 15 amino acids and has a net charge per residue of greater than 0.4,
wherein the first layer polypeptide is at least 15 amino acids long, and has a balance of charge at pH 7 greater than or equal to approximately one-half of the total length of the first layer polypeptide;
wherein the first layer polypeptide comprises a therapeutic agent reversibly covalently linked to the N-terminus or the C-terminus of the first layer polypeptide; and
wherein a second layer comprises a second layer polyelectrolyte comprising a polycationic material or a polyanionic material having a molecular weight of greater than 1,000 and at least 5 charges per molecule, wherein the second layer does not comprise a polypeptide.
2. The multilayer film of claim 1 , wherein the polypeptide and the therapeutic agent both comprise sulfhydryl groups and the reversible linkage is a disulfide bond.
3. The multilayer film of claim 1 , wherein an alcohol, an amine or a carboxylic acid group of the therapeutic agent is covalently attached to the N-terminus, or the C-terminus of the polypeptide.
4. The multilayer film of claim 1 , wherein attachment of the therapeutic agent to the peptide is done via the incorporation of a linker between the active agent and the peptide, wherein the linker comprises a functional pendant group.
5. The multilayer film of claim 4 , wherein the functional pendant group comprises a carboxylate, an alcohol, a thiol, an oxime, a hydraxone, a hydrazide, or an amine group.
6. The multilayer film of claim 1 , wherein the film is in the form of a microcapsule.
7. The multilayer film of claim 1 , wherein the film is formed on a substrate.
8. The multilayer film of claim 7 , wherein the substrate comprises a medical device.
9. A method of controllably releasing a therapeutic agent from a polypeptide multilayer film, comprising
providing the polypeptide multilayer film of claim 1 , and
contacting the film with a stimulus suitable to stimulate release of the therapeutic agent from the reversible linkage.
10. The method of claim 9 , wherein the reversible linkage is a disulfide bond and the stimulus is a reducing agent.
11. The method of claim 9 , wherein the reversible linkage is an amide, a thioester, an ester, an ether, a thioether, a carbonate, an anhydride, an orthoester, a hydroxamic acid, a hydrazone, sulfonamide, sulfonic esters, or a carbamate; and the stimulus is the pH environment of the bloodstream and/or alimentary tract.
12. The method of claim 9 , wherein the stimulus is enzymatic action on the polypeptide-therapeutic agent linkage.
13. The method of claim 9 , wherein the film is in the form of a microcapsule.
14. The method of claim 9 , wherein the film is formed on a substrate.
15. The method of claim 14 , wherein the substrate comprises a medical device.
16. A method of assembling a polypeptide multilayer film, comprising
disposing a second layer polyelectrolyte onto a substrate, wherein the second layer polyelectrolyte comprising a polycationic material or a polyanionic material having a molecular weight of greater than 1,000 and at least 5 charges per molecule, wherein the second layer does not comprise a polypeptide; and
disposing a first layer polypeptide on the second layer polyelectrolyte, wherein the first layer polypeptide comprises one or more first amino acid sequence motifs,
wherein the one or more first amino acid sequence motifs consists of 5 to 15 amino acids and has a net charge per residue of greater than 0.4,
wherein the first layer polypeptide is at least 15 amino acids long, and has a balance of charge at pH 7 greater than or equal to approximately one-half of the total length of the first layer polypeptide; and
wherein the first layer polypeptide comprises a therapeutic agent covalently reversibly linked to the the N-terminus or the C-terminus first layer polypeptide.
17. The method film of claim 16 , wherein the polypeptide and the therapeutic agent both comprise sulfhydryl groups and the reversible linkage is a disulfide bond.
18. The method of claim 16 , wherein the substrate comprises a medical device.